Jeffrey Hubbell, Ph.D. is Professor of Biomedical Engineering at the Integrative Biosciences Institute and the Institute for Chemical Sciences and Engineering at Ecole Polytechnique Fédérale de Lausanne, Switzerland and is an Adjunct Professor of Surgery at the Diabetes Research Institute. He also serves as the director of the Integrative Biosciences Institute.
World renowned for his innovative contributions in biological and chemical engineering, Dr. Hubbell’s research focuses on the development of novel biomaterials with a special interest in tissue engineering and the targeted delivery of new drugs and activated molecules to stimulate tissue regeneration as well as establish immune tolerance.
Using biocompatible polymers, Dr. Hubbell and the DRI’s tissue engineering team will be testing these materials for their ability to protect insulin-producing islet cells from immune attack and inflammatory reactions after transplantation.
He is also exploring methods to deliver low-dose immunosuppression at the islet transplant site which could eliminate the use of currently available systemic drug delivery and their related side effects.
After he received his doctorate in chemical engineering from Rice University in 1986, Dr. Hubbell joined the faculty at the University of Texas. In 1994 he accepted an appointment as professor of chemical engineering at The California Institute of Technology. In 1997, Dr. Hubbell moved to Switzerland to head the Institute of Biomedical Engineering.
In addition to serving as an expert on many scientific panels, Dr. Hubbell has contributed to more than 70 patents and has co-authored more than 200 scientific publications.